J1265 HCPCS code: Injection, dopamine hcl, 40 mg
J1265 is the HCPCS Level II code for injection, dopamine hcl, 40 mg. In 2024 Medicare paid an average of $0.60 per service for J1265 across 28,306 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 230 per day on DME suppliers. Medicare volume fell 6% from 2022 to 2024 (30,026 to 28,306 services). In 2024, 15 suppliers billed Medicare for J1265 (purchases), serving 19 beneficiaries; New York, Texas, California accounted for 88% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2006-01-01 |
| Last action effective | 2006-01-01 |
Who bills J1265 (2024)
| Measure | Value |
|---|---|
| Suppliers billing rentals | — |
| Suppliers billing purchases | 15 |
| Referring clinicians | 27 |
| Medicare beneficiaries | 19 |
| States with claims | 5 |
| Share of services in top 3 states (New York, Texas, California) | 88% |
| Year | Suppliers | Beneficiaries |
|---|---|---|
| 2022 | 20 | 24 |
| 2023 | 18 | 29 |
| 2024 | 15 | 19 |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J1265, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 30,026 | 24 | $0.61 | $0.48 |
| 2023 | 37,582 | 29 | $0.66 | $0.52 |
| 2024 | 28,306 | 19 | $0.77 | $0.60 |
States with the most J1265 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| New York | 11,083 | $0.60 |
| Texas | 6,419 | $0.59 |
| California | 6,213 | $0.59 |
| New Jersey | 2,936 | $0.61 |
| Missouri | 390 | $0.57 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| DME suppliers | 230 | Clinical: Data |
| outpatient hospital claims | 100 | Clinical: Data |
| practitioner claims | 20 | Clinical: Data |
What changed for J1265
- 2006-01-01: J1265 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J1265?
J1265 is the HCPCS Level II code for injection, dopamine hcl, 40 mg. Short descriptor: "Dopamine injection".
How much does Medicare pay for J1265?
In 2024, the average Medicare payment was $0.60 per service (average allowed $0.77).
Does Medicare cover J1265?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J1265 can be billed per day?
230 on DME suppliers; 100 on outpatient hospital claims; 20 on practitioner claims (NCCI medically unlikely edits).
Related J12 codes
- J1200 — Injection, diphenhydramine hcl, up to 50 mg
- J1201 — Injection, cetirizine hydrochloride, 0.5 mg
- J1202 — Miglustat, oral, 65 mg
- J1203 — Injection, cipaglucosidase alfa-atga, 5 mg
- J1205 — Injection, chlorothiazide sodium, per 500 mg
- J1212 — Injection, dmso, dimethyl sulfoxide, 50%, 50 ml
- J1230 — Injection, methadone hcl, up to 10 mg
- J1240 — Injection, dimenhydrinate, up to 50 mg
- J1245 — Injection, dipyridamole, per 10 mg
- J1250 — Injection, dobutamine hydrochloride, per 250 mg
- J1260 — Injection, dolasetron mesylate, 10 mg
- J1267 — Injection, doripenem, 10 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J1265
- Watch J1265 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J1265
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.